A rare case of myasthenia gravis with coexisting muscular dystrophy by Aftab, Sommayya et al.
Pakistan Journal of
Neurological Sciences (PJNS)
Volume 9 | Issue 2 Article 6
4-2014
A rare case of myasthenia gravis with coexisting
muscular dystrophy
Sommayya Aftab
The Children’s Hospital & ICH Lahore, sommayya_aftab@yahoo.com
M Haroon Hamid
The Children’s Hospital & ICH Lahore
Tipu Sultan
The Children’s Hospital & ICH Lahore
Follow this and additional works at: http://ecommons.aku.edu/pjns
Part of the Neurology Commons
Recommended Citation
Aftab, Sommayya; Hamid, M Haroon; and Sultan, Tipu (2014) "A rare case of myasthenia gravis with coexisting muscular dystrophy,"
Pakistan Journal of Neurological Sciences (PJNS): Vol. 9: Iss. 2, Article 6.
Available at: http://ecommons.aku.edu/pjns/vol9/iss2/6
A RARE CASE OF MYASTHENIA GRAVIS WITH COEXISTING
MUSCULAR DYSTROPHY
Dr. Sommayya Aftab1, Dr.  M Haroon Hamid1, Dr.  Tipu Sultan2 
1 Paediatric Critical Care Unit, The Children’s Hospital & ICH Lahore
2 Dept of Paediatric Neurology, The Children’s Hospital & ICH Lahore
Correspondence to: Dr. Sommayya aftab, 599-f block, gulshan-e-ravi, lahore. Sommayya_aftab@yahoo.com. Contact: 092 03314941549
Date of Submission: March 22, 2014, Date of Revision: June 17, 2014, Date of Acceptance: June 18, 2014
ABSTRACT
Myasthenia gravis (MG) is an autoimmune disease in which antibodies are directed against postsynaptic membrane of 
neuromuscular junction, resulting in muscle weakness and fatigability. We report a rare case of an 11 years old boy 
who was a known case of myasthenia gravis presented with progressive weakness and wasting of facial and limb 
musculature and was found to have coexisting muscular dystrophy most like facioscapulohumeral muscular dystrophy 
(FSHD).
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INTRODUCTION
Myasthenia gravis is a chronic disease characterized by 
rapid fatigability of striated muscle. The most common 
cause is an immune mediated neuromuscular blockade. 
In its juvenile form ptosis and some degree of extraocu-
lar muscle weakness are the earliest and most constant 
signs. Rapid fatigue of muscle is characteristic feature of 
myasthenia gravis that distinguish it from other neuro-
muscular disorders (1). Previous authors have observed 
rare coexistence of myasthenia gravis with different 
types of Muscular dystrophy including myotonic dystro-
phy (2), limb girdle muscular dystrophy (3) and familial 
facioscapulohumeral muscular dystrophy (FSHD)(4, 5, 6). 
However most of these cases are seen in the adult 
population.
CASE SUMMARY
An 11 years old boy known case of myasthenia gravis 
was admitted in pediatric intensive care Unit (PICU) with 
complain of progressive weakness and wasting of face 
and limbs since last 4 months and respiratory distress 
since last 4 days. He was diagnosed as case of myas-
thenia gravis 2 years back when he presented with 
bilateral ptosis, loss of neck holding, and opthalmople-
gia. His EMG done at that time was normal but NCS 
showed a decremental response on repeated nerve 
stimulation. He was put on anticholinesterase inhibitors, 
initially  for few months he showed some improvement 
but later on his  weakness progressively  increases to 
involve all four limb  but more marked in upper limb. On 
examination he was conscious, oriented but emaciated 
child with obvious facial wasting and bilateral winging of 
scapula. He was having bilateral ptosis and opthalmo-
plegia. He was vitally stable child with GCS of 15/15. He 
had reduced tone, diminished reflexes and power of 2/5 
in all four limbs with non specific babinski bilaterally. Her 
chest had right sided crepitation with wheeze. Rest of 
examination was unremarkable. He was admitted to 
PICU because he developed type 2 respiratory failure 
due to pneumonia and was put on non-invasive 
mechanical ventilation. He was given anticholinesterase 
inhibitors and IVIG to treat myasthenic crises but patient 
showed no improvement. All his routine examination 
including CBC, renal profile. Liver function test, serum 
electrolytes, CRP, blood and urine culture were normal. 
CXR shows right sided infiltrates. His CPK level was 
found to be160ul and LDH 1044ul. Tensilon test was 
refused by the parents. His mucle biobsy was done 
under local anesthesia from right deltoid muscle which 
showed variable sized muscle fibers with internalization 
of nuclei, increase connective tissue infiltration and 
degeneration of muscle fibers suggesting muscular 
dystrophy. The patient progressive weakness was due to 
this muscular dystrophy that’s why it’s not responding to 
any anticholinestrase inhibitors or IVIG. However by 
intensive care, physiotherapy, non invasive ventilation 
and antibiotics patient pneumonia settled and he was 
off ventilator on 20th day of admission. He was 
discharged with power of 4/5 in lower limb and 3/5 in 
upper limb (wheel chair dependant). At discharge he 
was given anticholinestase inhibitors, multivitamin and 
advised physiotherapy. His parents were counseled 
about the disease and advised proper follow up but they 
are non compliant to follow up. So on basis of clinical 
features, EMG showing decremental response with 
muscular dystrophy finding on muscle biobsy he was 
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diagnosed as a case of myasthenia gravis with coexisting 
muscular dystrophy most likely facioscapulohumeral 
dystrophy. 
DISCUSSION
Juvenile Myasthenia gravis is a rare autoimmune disor-
der of childhood which is characterized by the neuro-
muscular blockade leading to rapid fatigability of striated 
muscle. It is one of the few neuromuscular disease in 
which EMG is diagnostic. A decremental response is 
seen on repetitive nerve stimulation. Therapeutic options 
includes cholinesterase inhibiting drugs, steroids, 
thymectomy. In resistant cases plasmapheresis, IV 
immunoglobulins and rituximab (monoclonal antibody to 
B cell CD20 antigen) may be helpful (1). Fascioscapulo-
humeral dystrophy is a third most common inherited 
muscular dystrophy presented with slowly progressive 
weakness and wasting of facial, shoulder girdle and 
sometimes limb musculature (7). Bulbar muscles are 
typically spared in FSHD. The clinical severity is wide 
ranging from asymptomatic to wheel chair dependant. 
Serum CK and other enzymes vary greatly ranging from 
normal to elevation in several thousands. EMG reveal 
non specific myopathic changes. Diagnostic molecular 
testing in idvisual cases and within families is indicated 
for prediction. Muscle biobsy distinguish it fron other 
neuromuscular disorders. No effective pharmacological 
treatment is available yet (8). The coexistence of MG and 
FSHD has also been described previously. Asadollahi et 
al described coexistence of FSHD and MG in a 70 years 
old man (4, 5, 6). There was another report by Mcconigal et 
al  describing occurrence of MG in a  56 years old known 
patient of FSHD (5). Sansone et al reported 69 yaers old 
known case of FSHD presented with  sudden deteriora-
tion of muscle weakness with bulbar involvement and 
was found to have concurrent MG(6). Our case is a rare 
coexistence of FSHD with MG as no single report had 
been observed in pediatric population yet. Theoretically 
it is related to breaking of immune tolerance to acety-
lecholine receptors as a result of muscle fibre degenera-
tion (9). Other theory could be role of immune mechanism 
in pathogenesis of FSHD but these patients donot 
benefit from  prednisolone treatment (10).
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